Preparing for the next flu pandemic

British Medical Journal

Volumn 334, Issue 7588, 2007, Pages 268-269

  Wei, Shen Lim ^a   Thomson, Anne ^b   Little, Paul ^c  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIVIRUS AGENT; DOXYCYCLINE; OSELTAMIVIR;

AVIAN INFLUENZA; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; DISEASE TRANSMISSION; EDITORIAL; FLUID THERAPY; HEALTH CARE; HEALTH SERVICE; HUMAN; PANDEMIC; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; VIRUS PNEUMONIA; VIRUS TRANSMISSION; EPIDEMIC; HEALTH CARE PLANNING; INFLUENZA; INFLUENZA VIRUS A H5N1; NOTE; UNITED KINGDOM;

ANTIVIRAL AGENTS; DISEASE OUTBREAKS; GREAT BRITAIN; HEALTH PLANNING; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; PRACTICE GUIDELINES;

EID: 33847163125     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39101.628715.80     Document Type: Editorial

References (15)

1. Epidemiology of WHO-confirmed human cases of avian influenza A(H5N1) infection. Wkly Epidemiol Rec 2006;81:249-57.
2. Mounier-Jack S, Coker RJ. How prepared is Europe for pandemic influenza? Analysis of national plans. Lancet 2006;367:1405-11.
3. Provisional guidelines from the British Infection Society, British Thoracic Society and Health Protection Agency in collaboration with the Department of Health. Pandemic flu: the clinical management of patients with an influenza-like illness during an influenza pandemic. Thorax 2007;62(suppl 1):i1-46;
4. J Infect 2006;53(suppl 1)S1-S8.
5. Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP. Does this patient have influenza? JAMA 2005;293:987-97.
6. Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature 2006;442:448-52.
7. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003;163:1667-72.
8. Anon. Some aspects of the recent epidemic of influenza in Dundee. BMJ 1958;1:908-13.
9. Abrahams A, Hallows N, French H. Influenzo-pneumococcal and influenzo-streptococcal septicaemia: epidemic influenzal "pneumonia" of highly fatal type and its relation to "purulent bronchitis". Lancet 1919;1:1-11.
10. Schwarzmann SW, Adler JL, Sullivan RJ Jr, Marine WM. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. Arch Intern Med 1971;127:1037-41.
11. Neuzil KM, Zhu Y, Griffin MR, Edwards KM, Thompson JM, Tollefson SJ, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 2002;185:147-52.
12. Tsiodras S, Mooney J, Hatzakis A. The role of combined antiviral therapy in pandemic influenza. BMJ 2007 doi: 10.1136/bmj.39105.428981. BE.
13. Oswald NC, Shooter RA, Curwen MP. Pneumonia complicating Asian influenza. BMJ 1958;2:1305-11.
14. Robertson L, Caley JP, Moore J. Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. Lancet 1958;2:233-6.
15. Hageman JC, Uyeki TM, Francis JS, Jernigan DB, Wheeler JG, Bridges CB, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-4 influenza season. Emerg Infect Dis 2006;12:894-9.